Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

E.D. Tex.

Allergan, Inc. v. Sandoz Inc, No. 2:09-cv-00097 (E.D. Tex. June 28, 2011)

Granted in Part
Court
U.S. District Court for the Eastern District of Texas, Marshall Division
Case No.
No. 2:09-cv-00097, Dkt. No. 191
Decided
June 28, 2011
Judge
See opinion
Document
Memorandum Opinion and Order
Docket Entry
MEMORANDUM OPINION and ORDER - In conclusion, the Court STRIKES the expert report of Dr. Kay and precludes Dr. Kay from testifying at trial. The Court also STRIKES any portion of Defendants other expert reports that rely on Dr. Kays opinion…
Length
6 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Pending before the Court is Plaintiff’s Allergan, Inc. (“Allergan ”) Motion for Sanctions for Defendants' Violation of the Court Entered Protective Order (Dkt. No 179), and Defendants’ Sandoz, Inc., Alcon Laboratories, Inc., Alcon Research, Ltd., Alcon, Inc ., Falcon Pharmaceuticals, Ltd., Apotex, Inc., Apotex Corp., and Watson Laboratories, Inc. (“Defendants”) Emergency Motion to Qualify Dr. Richard Kay Under the Protective Order (Dkt. No. 188) . The Court GRANTS Allergan’s m otion for s anctions and DENIES Defendants’ Emergency Motion to Qualify Dr.